AbbVie's $63 billion mega-deal for Botox-maker Allergan is the pharma industry's latest bet that bigger is better. But the deal is already facing big questions.
This is a Business Insider Prime story. Click the link below to read it.
- BSE and NSE suspends trading in shares of Dewan Housing Finance Corporation Ltd (DHFL) from Monday
- Byju's most valuable startup in India and 11th in the world with a valuation of $16.5 billion
- India witnesses decline in daily COVID-19 cases with 80,834 fresh cases in last 24 hours, lowest since April 1
- Delhi reports its lowest daily COVID-19 cases in 104 days, records 213 single day COVID-19 cases
- Here’s how to recharge your Reliance Jio on WhatsApp